Dec. 18, 2024 – Do the same treatments that help children focus and manage hyperactivity and attention problems also work for adults with attention deficit hyperactivity disorder (ADHD)? It ...

The FDA has approved cosibelimab, a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer. It is the first and only PD-L1 blocker approved to treat ...